Elevation of Anti-cytokeratin 19 Antibody in Sera of the Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Associated With Collagen Vascular Disorders
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
It has been suggested that cytokeratin 19 is expressed in regenerated bronchoepithelial cells in patients with pulmonary fibrosis, and serum cytokeratin 19 fragment is elevated in patients with pulmonary fibrosis. We hypothesized that serum antibodies to cytokeratin 19 may be formed in patients with pulmonary fibrosis. To prove the existence of anti-cytokeratin 19 antibodies in patients' sera, human recombinant cytokeratin 19 was stained with patients' sera by a Western immunoblot. Then, we tried to establish an enzyme-linked immunosorbent assay to quantitate anti-cytokeratin 19 antibody in the sera of patients with idiopathic pulmonary fibrosis (IPF) and pulmonary fibrosis associated with collagen vascular disorders (PF-CVD). We demonstrated the anti-cytokeratin 19 antibody in patient' sera by a Western immunoblot. In patients with IPF and PF-CVD, significantly high anti-cytokeratin 19 antibody was demonstrated compared with normal volunteers, patients with chronic bronchitis, and patients with pneumonia. These results suggest that anti-cytokeratin 19 antibody may have played a role in the process of lung injury in pulmonary fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A variety of novel autoantibodies targeting neoepitopes have been reported in IPF (159–163), with many of the targets being structural cell proteins, such as desmoplakin (164) and periplakin (159).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [163]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385 · cited 1×
“Then, proteins were electrophoretically transferred onto nitrocellulose membrane by the method of Towbin et al [19].”
MethodReynolds, H. Y., Fulmer, J. D., Kazmierowski, J. A., Roberts, W. C., Frank, M. M., & Crystal, R. G. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108615 · Cited by 557 · cited 11×
“Of the 37 patients, 26 had IPF and 11 had PF-CVD (6 had rheumatoid arthritis, 4 had dermatomyositis, and 1 had Sjo¨gren’s syndrome).”
BackgroundInfluentialCrystal, R. G., Bitterman, P. B., Rennard, S. I., Hance, A. J., & Keogh, B. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401263100406 · Cited by 463 · cited 1×
“are characterized by the accumulation of neutrophils and mononuclear cells [3, 11].”
Background(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90233-n · Cited by 320 · cited 2×
“In addition, although the precise mechanisms of their generation are unknown, fragments of cytokeratin 19 are soluble in serum and can be detected with the aid of monoclonal antibodies in patients with lung cancer [12, 13].”
BackgroundThe Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Proteina
SELKOE, D. J., YAMAZAKI, T., CITRON, M., PODLISNY, M. B., KOO, E. H., TEPLOW, D. B., & HAASS, C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34401.x · Cited by 205 · cited 1×
“fragment was reported to be 37 kDa and C-terminal of cytokeratin 19 was released [15], it is possible that digestion at the site of Met-Asp took place to make the antigenic epitope known as BM 19.21 (Fig. 5). In addition, it has been reported that several proteases can cleave the Met-Asp site [1, 8, 9, 16 ].”
BackgroundInfluentialPrognostic Role of Eosinophils in Pulmonary Fibrosis
Peterson, M. W., Monick, M., & Hunninghake, G. W. (1987) · Chest · doi:10.1378/chest.92.1.51 · Cited by 164 · cited 1×
“are characterized by the accumulation of neutrophils and mononuclear cells [3, 11].”
BackgroundInhibition of Amyloid β-Protein Production in Neural Cells by the Serine Protease Inhibitor AEBSF
Citron, M., Diehl, T. S., Capell, A., Haass, C., Teplow, D. B., & Selkoe, D. J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80290-1 · Cited by 106 · cited 1×
“In addition, it has been reported that several proteases can cleave the Met-Asp site [1, 8, 9, 16].”
BackgroundEVALUATION OF TUMOUR ANGIOGENESIS AS A PROGNOSTIC MARKER IN MALIGNANT MESOTHELIOMA
KUMAR-SINGH, S., VERMEULEN, P. B., WEYLER, J., SEGERS, K., WEYN, B., VAN DAELE, A., DIRIX, L. Y., VAN OOSTEROM, A. T., & VAN MARCK, E. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199706)182:2<211::aid-path834>3.0.co;2-d · Cited by 84
Stigbrand, T. I., Andrés, C., Bellanger, L., Omary, M. B., ller, H. B. U., Bonfrer, H., Brundell, J., EINARSSON, R., Erlandsson, A., Johansson, A., et al. (1998) · Tumor Biology · doi:10.1159/000029984 · Cited by 77
Cytokeratins as Serum Markers in Lung Cancer: A Comparison of CYFRA 21-1 and TPS
Pujol, J.-L., Grenier, J., Parrat, É., Lehmann, M., Lafontaine, T., Quantin, X., & Michel, F. B. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810612 · Cited by 74 · cited 2×
“In addition, although the precise mechanisms of their generation are unknown, fragments of cytokeratin 19 are soluble in serum and can be detected with the aid of monoclonal antibodies in patients with lung cancer [12, 13].”
BackgroundIyonaga, K., Miyajima, M., Suga, M., Saita, N., & Ando, M. (1997) · The Journal of Pathology · Cited by 55
Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis
Wallace, W. A., Roberts, S. N., Caldwell, H., Thornton, E., Greening, A. P., Lamb, D., & Howie, S. E. (1994) · Thorax · doi:10.1136/thx.49.3.218 · Cited by 52
Hirakata, Y., Kobayashi, J., Sugama, Y., & Kitamura, S. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08050689 · Cited by 31 · cited 1×
“Furthermore, reports show the elevation of cytokeratin 19 fragment levels in serum and bronchoalveolar lavage fluid (BALF) in interstitial lung diseases [5, 18].”
BackgroundDobashi, N., Fujita, J., OHTSUKI, Y., Yamadori, I., Yoshinouchi, T., Kamei, T., Tokuda, M., Hojo, S., Okada, H., & Takahara, J. (1998) · Thorax · doi:10.1136/thx.53.11.969 · Cited by 30 · cited 10×
“Of the 37 patients, 26 had IPF and 11 had PF-CVD (6 had rheumatoid arthritis, 4 had dermatomyositis, and 1 had Sjo¨gren’s syndrome).”
BackgroundSelf-citationMarks, N., Berg, M. J., Chi, L.-M., Choi, J. H. K., Durrie, R., Swistok, J., MAKOFSKE, R. C., Danho, W., & Sapirstein, V. S. (1994) · Peptides · doi:10.1016/0196-9781(94)90188-0 · Cited by 24
Marks, N., Berg, M. J., Sapirstein, V. S., Durrie, R., Swistok, J., MAKOFSKE, R. C., & Danho, W. (1995) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1995.tb00602.x · Cited by 17 · cited 1×
“In addition, it has been reported that several proteases can cleave the Met-Asp site [1, 8, 9, 16].”
BackgroundProduction of Cytokeratin 19 Fragment by Human Squamous Lung Cancer Cell Lines
Satoh, H., Ishikawa, H., Fujiwara, M., Yamashita, Y., Ohtsuka, M., Ogata, T., Hasegawa, S., & Kamma, H. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.5.9160842 · Cited by 14 · cited 1×
“fragment was reported to be 37 kDa and C-terminal of cytokeratin 19 was released [15], it is possible that digestion at the site of Met-Asp took place to make the antigenic epitope known as BM 19.”
BackgroundSuzuki, A., Masuda, T., Koito, N., Suzuki, T., Mita, S., Matsuoka, Y., & Irimajiri, S. (1996) · PubMed · Cited by 5
土橋, 尚. (1999) · Medical Entomology and Zoology · doi:10.11501/3148234 · Cited by 4
Cited by
Molecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 418
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
Fox, R. I., Stern, M., & Michelson, P. (2000) · Current Opinion in Rheumatology · doi:10.1097/00002281-200009000-00007 · Cited by 248
Interstitial lung disease in polymyositis and dermatomyositis
Hirakata, M., & Nagai, S. (2000) · Current Opinion in Rheumatology · doi:10.1097/00002281-200011000-00005 · Cited by 134
The Multifaceted Aspects of Interstitial Lung Disease in Rheumatoid Arthritis
Cavagna, L., Monti, S. M., Grosso, V., Boffini, N., Scorletti, E., Crepaldi, G., & Caporali, R. F. (2013) · BioMed Research International · doi:10.1155/2013/759760 · Cited by 138
Metadata
- Authors
- Fujita, J., Dobashi, N., Ohtsuki, Y., Yamadori, I., Yoshinouchi, T., Kamei, T., Tokuda, M., Hojo, S., Okada, H., & Takahara, J.
- Affiliations
- Kagawa University (JP)
- Kochi Medical School Hospital (JP)
- Okayama University (JP)
- Gamagori City Hospital (JP)
- Kagawa Prefectural Central Hospital (JP)
- Venue
- Lung
- Published
- 1999-09
- Volume
- 177
- Issue
- 5
- Pages
- 311-319
- ISSN
- 0341-2040 (ISSN-L)
- OpenAlex
- W2040761197
- Cited by
- 45
- References
- 19
- Citations by year
- 2026: 2 · 2023: 1 · 2022: 2 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 1 · 2013: 4 · 2012: 4
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Lung (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- cytokeratin 19, idiopathic pulmonary fibrosis, serum autoantibodies, lung injury
- MeSH terms
- Adult, Aged, Aged, 80 and over, Arthritis, Rheumatoid, Autoantibodies, Collagen Diseases, Dermatomyositis, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoenzyme Techniques, Keratins, Male, Middle Aged, Pulmonary Fibrosis, Sjogren's Syndrome, Blotting, Western
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.